BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28096923)

  • 1. Role of neutrophil-to-lymphocyte ratio in prediction of Gleason score upgrading and disease upstaging in low-risk prostate cancer patients eligible for active surveillance.
    Gokce MI; Tangal S; Hamidi N; Suer E; Ibis MA; Beduk Y
    Can Urol Assoc J; 2016; 10(11-12):E383-E387. PubMed ID: 28096923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients.
    Ferro M; Musi G; Serino A; Cozzi G; Mistretta FA; Costa B; Bianchi R; Cordima G; Luzzago S; Di Trapani E; Tagliabue E; Vartolomei MD; Terracciano D; Cassatella MC; Salvatici M; Conti A; Sandri MT; Cioffi A; Turetti M; Catellani M; Bottero D; Matei DV; Mirone V; de Cobelli O
    Urol Int; 2019; 102(1):43-50. PubMed ID: 30408799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does extent of prostate-specific antigen fluctuation can predict Gleason score upgrading in low-risk prostate cancer patients?
    Hamidi N; Atmaca AF; Canda AE; Keske M; Ardıçoğlu A
    Turk J Urol; 2019 Dec; 45(Supp. 1):S42-S48. PubMed ID: 30183609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is neutrophile to lymphocyte ratio a predictor of Gleason score upgrading according to risk classifications in patients with prostate cancer.
    Karadağ S; Ekşi M; Özdemir O; Akkaş F; Arikan Y; Özlü DN; Çolakoğlu Y; Aliş D; Şahin S; Tuğcu V
    Arch Esp Urol; 2021 Jul; 74(6):599-605. PubMed ID: 34219063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of inflammatory factors in prediction of Gleason score and its upgrading in localized prostate cancer patients after radical prostatectomy.
    Wang S; Ji Y; Ma J; Du P; Cao Y; Yang X; Yu Z; Yang Y
    Front Oncol; 2022; 12():1079622. PubMed ID: 36713540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer.
    Kwon YS; Han CS; Yu JW; Kim S; Modi P; Davis R; Park JH; Lee P; Ha YS; Kim WJ; Kim IY
    Clin Genitourin Cancer; 2016 Feb; 14(1):e1-8. PubMed ID: 26341038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.
    Flood TA; Schieda N; Keefe DT; Breau RH; Morash C; Hogan K; Belanger EC; Mai KT; Robertson SJ
    Virchows Arch; 2016 Sep; 469(3):313-9. PubMed ID: 27394432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomy.
    Özsoy M; Moschini M; Fajkovic H; Soria F; Seitz C; Klatte T; Gust K; Briganti A; Karakiewicz PI; Roupret M; Kramer G; Shariat SF
    Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):100-105. PubMed ID: 29230007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can systemic immune-inflammation index and hematologic parameters aid in decision-making for active surveillance or curative treatment in low-risk prostate cancer?
    Baylan B; Ulusoy K; Ekenci B; Kartal IG
    Asian J Surg; 2024 Mar; 47(3):1360-1365. PubMed ID: 38065745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.
    Ferro M; Lucarelli G; Bruzzese D; Di Lorenzo G; Perdonà S; Autorino R; Cantiello F; La Rocca R; Busetto GM; Cimmino A; Buonerba C; Battaglia M; Damiano R; De Cobelli O; Mirone V; Terracciano D
    Oncotarget; 2017 Mar; 8(11):18424-18434. PubMed ID: 27793023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Values of Systemic Immune-Inflammation Index and Neutrophil-Lymphocyte Ratio in Predicting Biochemical Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy.
    Wang S; Yang X; Yu Z; Du P; Sheng X; Cao Y; Yan X; Ma J; Yang Y
    Front Oncol; 2022; 12():907625. PubMed ID: 35719913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy.
    Gao Y; Jiang CY; Mao SK; Cui D; Hao KY; Zhao W; Jiang Q; Ruan Y; Xia SJ; Han BM
    Asian J Androl; 2016; 18(4):639-43. PubMed ID: 26732103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upgrading and upstaging in prostate cancer: From prostate biopsy to radical prostatectomy.
    D'Elia C; Cerruto MA; Cioffi A; Novella G; Cavalleri S; Artibani W
    Mol Clin Oncol; 2014 Nov; 2(6):1145-1149. PubMed ID: 25279213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perineural invasion on biopsy is associated with upstaging at radical prostatectomy in Gleason score 3 + 4 = 7 prostate cancer.
    Flood TA; Schieda N; Keefe DT; Morash C; Bateman J; Mai KT; Belanger EC; Robertson SJ; Breau RH
    Pathol Int; 2016 Nov; 66(11):629-632. PubMed ID: 27709739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are more low-risk prostate cancers detected by repeated biopsy? A retrospective pilot study.
    Lee SJ; Hwang I; Hwang EC; Jung SI; Kang TW; Kwon DD; Park K
    Korean J Urol; 2013 Jun; 54(6):364-8. PubMed ID: 23789043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of Whether Apex or Non-Apex Prostate Cancer Is the Best Candidate for the Use of Prostate-Specific Antigen Density to Predict Pathological Grade Group Upgrading and Upstaging after Radical Prostatectomy.
    Huang C; He S; He Q; Gong Y; Song G; Zhou L
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836195
    [No Abstract]   [Full Text] [Related]  

  • 17. Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance.
    de Cobelli O; Terracciano D; Tagliabue E; Raimondi S; Galasso G; Cioffi A; Cordima G; Musi G; Damiano R; Cantiello F; Detti S; Victor Matei D; Bottero D; Renne G; Ferro M
    Urol Oncol; 2015 May; 33(5):201.e1-8. PubMed ID: 25791753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6.
    Wang H; Gu L; Wu Y; Feng D; Duan J; Wang X; Huang Y; Wu S; Chen J; Luo G; Zhang X
    BMC Cancer; 2017 Sep; 17(1):629. PubMed ID: 28874127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High preoperative neutrophil-lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy.
    Lee H; Jeong SJ; Hong SK; Byun SS; Lee SE; Oh JJ
    World J Urol; 2016 Jun; 34(6):821-7. PubMed ID: 26449784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
    Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.